Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AAA614
i
Other names:
3B201, 3B 201, AAA-614, AAA 614, FAP2286, AAA614, 177Lu-FAP-2286, FAP 2286, 3B-201, FAP-2286
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
3B Pharma, Clovis, Novartis
Drug class:
Ionizing radiation emitter, FAP inhibitor
Related drugs:
‹
177Lu-satetraxetan-lilotomab (4)
ibritumomab tiuxetan (3)
Actinium-225 conjugated to daratumumab (2)
CLR 131 (2)
PNT2002 (2)
225Ac-FL-020 (1)
TLX250 (0)
177Lu-DTPA-omburtamab (0)
177Lu-LNC1003 (0)
177Lu-LNC1004 (0)
177Lu-LNC1010 (0)
177Lu-P17-087 (0)
177Lu-P17-088 (0)
177Lu-PSMA-R2 (0)
CYT 500 (0)
TLX591 (0)
90Y-NM600 (0)
TLX66 (0)
iodine I 131 tositumomab (0)
samarium-153 DOTMP (0)
EBTATE (0)
FF21101 (0)
ITM-91 (0)
epratuzumab Y-90 (0)
MVT-1075 (0)
186Re (0)
Radspherin (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
Re (0)
177Lu-DOTA-EB-FAPI (0)
BI 765179 (0)
MP0310 (0)
MP0317 (0)
NG-641 (0)
RG7827 (0)
SHR-7367 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
177Lu-satetraxetan-lilotomab (4)
ibritumomab tiuxetan (3)
Actinium-225 conjugated to daratumumab (2)
CLR 131 (2)
PNT2002 (2)
225Ac-FL-020 (1)
TLX250 (0)
177Lu-DTPA-omburtamab (0)
177Lu-LNC1003 (0)
177Lu-LNC1004 (0)
177Lu-LNC1010 (0)
177Lu-P17-087 (0)
177Lu-P17-088 (0)
177Lu-PSMA-R2 (0)
CYT 500 (0)
TLX591 (0)
90Y-NM600 (0)
TLX66 (0)
iodine I 131 tositumomab (0)
samarium-153 DOTMP (0)
EBTATE (0)
FF21101 (0)
ITM-91 (0)
epratuzumab Y-90 (0)
MVT-1075 (0)
186Re (0)
Radspherin (0)
lutetium-177 DOTA satoreotide (0)
67Cu MeCOSar octreotate (0)
Re (0)
177Lu-DOTA-EB-FAPI (0)
BI 765179 (0)
MP0310 (0)
MP0317 (0)
NG-641 (0)
RG7827 (0)
SHR-7367 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
FAP expression
Sarcoma
FAP expression
Sarcoma
AAA614
Sensitive: D – Preclinical
AAA614
Sensitive
:
D
AAA614
Sensitive: D – Preclinical
AAA614
Sensitive
:
D
FAP expression
Pancreatic Cancer
FAP expression
Pancreatic Cancer
AAA614
Sensitive: D – Preclinical
AAA614
Sensitive
:
D
AAA614
Sensitive: D – Preclinical
AAA614
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login